Product Information
GALANTAMINE HBR 8 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.4007 per EA under NDC 57237005060. Its NADAC has been published 646 times since Apr 9, 2014.
FDA first approved this application on Mar 29, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237005060
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GALANTAMINE HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090957FDA Approved
3/29/2011
TE Code
AB
On Market Since
3/29/2011
Pharmacological Classes
Price Statistics
The NADAC for GALANTAMINE HBR 8 MG TABLET has been published 646 times since Apr 9, 2014, and over the history we have for it it has declined 70.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4007 per EA |
|---|---|
| All-time high | $1.4470 (Jan 14, 2015) |
| All-time low | $0.3390 (Jan 22, 2025) |
| 52-week high | $0.5117 |
| 52-week low | $0.3701 |
| Median price | $0.5842 |
| Average price | $0.7379 |
| Largest weekly change | +57.2% (Jun 20, 2018) |
| Weeks tracked | 646 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GALANTAMINE HBR 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GALANTAMINE HBR 8 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.4007 per EA (NDC 57237005060), effective Aug 19, 2026.
How has the price of GALANTAMINE HBR 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for GALANTAMINE HBR 8 MG TABLET has declined 70.9%. It has been tracked across 646 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for GALANTAMINE HBR 8 MG TABLET?
Since Apr 9, 2014, the NADAC for GALANTAMINE HBR 8 MG TABLET has ranged from a low of $0.3390 (Jan 22, 2025) to a high of $1.4470 (Jan 14, 2015), with a median of $0.5842 per EA.
Are there cheaper alternatives to GALANTAMINE HBR 8 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as GALANTAMINE HBR 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GALANTAMINE HBR 8 MG TABLET?
GALANTAMINE HBR 8 MG TABLET (NDC 57237005060) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.